Second Sight Medical (EYES) Reports Q2 Loss of $0.17/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Second Sight Reports Second Quarter 2016 Financial Results
July 28, 2016 4:06 PM EDTSYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and six-month periods ended June 30, 2016.
Recent Company Highlights:
Completed oversubscribed Rights Offering, giving the Company access to an additional $19.5 million to fund ongoing trials and research; Generated net sales of $1.0 million in the second quarter of 2016 compared to $2.7 million in the second quarter of 2015;... MoreSecond Sight Announces Two Exclusive Distribution Agreements to Bring the Argus II Retinal Prosthesis to Taiwan and Iran
July 28, 2016 4:00 PM EDTSYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced plans to expand into Taiwan with Orient Europharma Co, Ltd. and Iran with Arshia Gostar Darman Co, Ltd. through exclusive agreements to distribute the Argus® II Retinal Prosthesis System ("Argus II").
In Taiwan, Orient Europharma is a well-established distributor deeply connected in the ophthalmology market. Taiwan is a densely populated state of 25 million people. Their... More
